| A perfect storm; towards reducing the risk of suicide in the medical profession MC AI Med J Aust 209 (9), 278-279, 2018 | | 2018 |
| A perfect storm: towards reducing the risk of suicide in the medical profession AI McCormack The Medical Journal of Australia 209 (9), 378-379, 2018 | 5 | 2018 |
| A phase 2 study of antisense oligonucleotide therapy directed at the GH receptor demonstrates lowering of serum IGF1 in patients with acromegaly. P Trainer, J Newell-Price, J Ayuk, S Aylwin, A Rees, W Drake, P Chanson, ... Endocrine Abstracts 37, 2015 | 2 | 2015 |
| A randomised, open-label, parallel group phase 2 study of antisense oligonucleotide therapy in acromegaly PJ Trainer, JDC Newell-Price, J Ayuk, SJB Aylwin, A Rees, W Drake, ... European journal of endocrinology 179 (2), 97-108, 2018 | 35 | 2018 |
| Aggressive pituitary tumors and pituitary carcinomas SMC De Sousa, AI McCormack Endotext [Internet], 2022 | 21 | 2022 |
| Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients P Burman, J Trouillas, M Losa, A McCormack, S Petersenn, V Popovic, ... European journal of endocrinology 187 (4), 593-605, 2022 | 51 | 2022 |
| Aggressive pituitary tumours and carcinomas: two sides of the same coin? J Trouillas, P Burman, A McCormack, S Petersenn, V Popovic, O Dekkers, ... European journal of endocrinology 178 (6), C7-C9, 2018 | 61 | 2018 |
| Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status AI McCormack, JAH Wass, AB Grossman European journal of clinical investigation 41 (10), 1133-1148, 2011 | 182 | 2011 |
| An AIP-positive R304X man with genetically and histologically distinct synchronous GH-secreting adenomas N Sheriff, M McCabe, RM Ghahan, S De Sousa, T Thomson, J Maag, ... CLINICAL ENDOCRINOLOGY 86, 60-60, 2017 | | 2017 |
| Antisense oligomer therapy directed at the GH receptor is associated with reduction in circulating GHBP levels P Trainer, J Newell-Price, J Ayuk, S Aylwin, A Rees, W Drake, P Chanson, ... Society for Endocrinology BES 2015 38, 2015 | | 2015 |
| Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician’s questions J Trouillas, ML Jaffrain-Rea, A Vasiljevic, O Dekkers, V Popovic, ... Reviews in Endocrine and Metabolic Disorders 21, 243-251, 2020 | 46 | 2020 |
| Assessment of magnetic resonance imaging criteria for the diagnosis of cavernous sinus invasion by pituitary tumors N Chang, JW Grayson, J Mangussi-Gomes, S Fung, R Alvarado, ... Journal of Clinical Neuroscience 90, 262-267, 2021 | 1 | 2021 |
| Atypical pituitary adenomas–investigation and validation of the 2004 who criteria TT Shein, ML Costin, A McCormack, A Parker, P Earls Pathology 45, S83-S84, 2013 | | 2013 |
| Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement S Petersenn, M Fleseriu, FF Casanueva, A Giustina, N Biermasz, ... Nature Reviews Endocrinology, 1-1, 2023 | | 2023 |
| Cardiovascular complications in pituitary gigantism (results of an international study) R Liliya, D Adrian, S Nalini, AN Luciana, B Anne, JR Marie-Lise, ... Endocrine Abstracts 57, 2018 | 3 | 2018 |
| Case report: a case of pituitary carcinoma treated with sequential dual immunotherapy and vascular endothelial growth factor inhibition therapy LS Lamb, HW Sim, AI McCormack Frontiers in Endocrinology 11, 576027, 2020 | 28 | 2020 |
| Changing the name of diabetes insipidus H Arima, DG Bichet, T Cheetham, M Christ-Crain, J Drummond, M Gurnell, ... Pituitary, 1-3, 2022 | 1 | 2022 |
| Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus H Arima, T Cheetham, M Christ-Crain, D Cooper, M Gurnell, ... Endocrine Connections 11 (11), 2022 | 30 | 2022 |
| Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus H Arima, T Cheetham, M Christ-Crain, DL Cooper, JB Drummond, ... Hormone Research in Paediatrics 95 (5), 405-407, 2022 | 13 | 2022 |
| Chicken or the egg: Cortisol dysregulation is frequent but overt Cushing's syndrome is rare in an unselected type 2 diabetes population N Sheriff, S De Sousa, N Manzoor, V Toogood, J Greenfield, G Jones, ... CLINICAL ENDOCRINOLOGY 89, 60-60, 2018 | | 2018 |
